- Home
- BLMN vs RZLT Comparison
BLMN vs RZLT Comparison
Compare BLMN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- RZLT
- Stock Information
- Founded
- BLMN 1988
- RZLT 2010
- Country
- BLMN United States
- RZLT United States
- Employees
- BLMN N/A
- RZLT N/A
- Industry
- BLMN Restaurants
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- BLMN Consumer Discretionary
- RZLT Health Care
- Exchange
- BLMN Nasdaq
- RZLT Nasdaq
- Market Cap
- BLMN 625.3M
- RZLT 713.4M
- IPO Year
- BLMN 2012
- RZLT N/A
- Fundamental
- Price
- BLMN $7.57
- RZLT $8.77
- Analyst Decision
- BLMN Hold
- RZLT Strong Buy
- Analyst Count
- BLMN 9
- RZLT 6
- Target Price
- BLMN $9.25
- RZLT $14.50
- AVG Volume (30 Days)
- BLMN 2.1M
- RZLT 1.6M
- Earning Date
- BLMN 11-07-2025
- RZLT 11-06-2025
- Dividend Yield
- BLMN 7.96%
- RZLT N/A
- EPS Growth
- BLMN N/A
- RZLT N/A
- EPS
- BLMN N/A
- RZLT N/A
- Revenue
- BLMN $3,933,993,000.00
- RZLT N/A
- Revenue This Year
- BLMN $1.43
- RZLT N/A
- Revenue Next Year
- BLMN $1.47
- RZLT N/A
- P/E Ratio
- BLMN N/A
- RZLT N/A
- Revenue Growth
- BLMN 2.47
- RZLT N/A
- 52 Week Low
- BLMN $6.09
- RZLT $2.22
- 52 Week High
- BLMN $17.57
- RZLT $9.72
- Technical
- Relative Strength Index (RSI)
- BLMN 57.74
- RZLT 59.75
- Support Level
- BLMN $7.18
- RZLT $8.72
- Resistance Level
- BLMN $7.56
- RZLT $9.72
- Average True Range (ATR)
- BLMN 0.28
- RZLT 0.55
- MACD
- BLMN 0.10
- RZLT -0.07
- Stochastic Oscillator
- BLMN 95.72
- RZLT 61.35
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.